Literature DB >> 6320247

Continuous amphetamine intoxication: an animal model of the acute psychotic episode.

G D Ellison, M S Eison.   

Abstract

When amphetamines are administered to humans every few hours for several days, either during the 'speed runs' of addicts or in controlled laboratory settings, the psychosis which reliably results is similar to paranoid schizophrenia in a number of important aspects. This unique regimen of drug intake, which involves the continuous presence of stimulants over a prolonged period of time, can be simulated in animals using subcutaneously implanted slow-release silicone pellets containing d-amphetamine base. Monkeys and rats implanted with these pellets develop stages of behavioural alterations which are somewhat similar in sequence to those observed in humans who have received frequent doses of amphetamine. An initial period of hyperactivity and exploratory behaviour is followed by the gradual development of motor stereotypies which become virtually incessant. A period of relative inactivity then appears which is followed, at 4-5 days after pellet implantation, by a late stage. This final stage is characterized by 'wet-dog' shakes, parasitotic-like grooming episodes, and a variety of other forms of hallucinatory-like behaviour. At about the same time there are distinctive and partially irreversible alterations in dopaminergic innervations of the caudate nucleus, but not in mesolimbic dopamine innervation of the nucleus accumbens or in several other neurotransmitter systems. Continuous amphetamine administration may reproduce some aspects of the prolonged excitation which accompanies an acute psychotic episode and may be a fruitful model for the clarification of the dopamine theory of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6320247     DOI: 10.1017/s003329170005145x

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  Selective neurotoxins, chemical tools to probe the mind: the first thirty years and beyond.

Authors:  R M Kostrzewa
Journal:  Neurotox Res       Date:  1999-09       Impact factor: 3.911

Review 2.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Neurol Clin       Date:  2011-06-24       Impact factor: 3.806

Review 3.  Cross-species assessments of motor and exploratory behavior related to bipolar disorder.

Authors:  Brook L Henry; Arpi Minassian; Jared W Young; Martin P Paulus; Mark A Geyer; William Perry
Journal:  Neurosci Biobehav Rev       Date:  2010-04-14       Impact factor: 8.989

4.  An escalating dose "binge" model of amphetamine psychosis: behavioral and neurochemical characteristics.

Authors:  D S Segal; R Kuczenski
Journal:  J Neurosci       Date:  1997-04-01       Impact factor: 6.167

5.  An escalating dose/multiple high-dose binge pattern of amphetamine administration results in differential changes in the extracellular dopamine response profiles in caudate-putamen and nucleus accumbens.

Authors:  R Kuczenski; D S Segal
Journal:  J Neurosci       Date:  1997-06-01       Impact factor: 6.167

Review 6.  Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Authors:  Daniel C Javitt; Robert A Sweet
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

Review 7.  Neurologic manifestations of chronic methamphetamine abuse.

Authors:  Daniel E Rusyniak
Journal:  Psychiatr Clin North Am       Date:  2013-04-11

Review 8.  Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia.

Authors:  Stacy A Castner; Patricia S Goldman-Rakic; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

9.  Behavioral sensitization: characterization of enduring changes in rotational behavior produced by intermittent injections of amphetamine in male and female rats.

Authors:  T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Cholecystokinin binding sites in the rat forebrain: effects of acute and chronic methamphetamine administration.

Authors:  T Suzuki; T Moroji
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.